Skip to main content
    S

    Scilex Holding Company (SCLX)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ

    $1.25
    -0.18 (-12.59%)

    Market Cap: $10.06M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Scilex Holding Company (SCLX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Scilex Holding Company are MIRA Pharmaceuticals, Inc. Common Stock (MIRA), Context Therapeutics (CNTX) and Soligenix (SNGX). By market cap, Scilex Holding Company ranks 8th of the 13 companies on this page; MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is the largest at $27.73M.

    Peer Comparison

    SCLX's ROIC of 143.5% is above the peer median of -109.0%, and its revenue growth of -22.8% is below the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Scilex Holding Company (SCLX)$10.06MN/A0.3x0.0%143.5%-22.8%0.00%
    MIRA Pharmaceuticals, Inc. Common Stock (MIRA)$27.73MN/AN/A0.0%N/A0.0%0.00%
    Context Therapeutics Inc (CNTX)$16.61MN/AN/A0.0%N/A0.0%0.00%
    Soligenix Inc. (SNGX)$7.50MN/AN/A0.0%N/A-100.0%0.00%
    Ensysce Biosciences Inc (ENSC)$8.14MN/A1.2x-280.5%-260.6%-15.1%0.00%
    Exicure Inc (XCUR)$7.07MN/AN/A0.0%N/A928.0%0.00%
    Phio Pharmaceuticals Corp (PHIO)$9.21MN/AN/A0.0%N/A0.0%0.00%
    Skye Bioscience, Inc. Common Stock (SKYE)$4.83MN/AN/A0.0%-3685.3%0.0%0.00%
    Psyence Biomedical Ltd. Common Shares (PBM)$12.00MN/AN/A0.0%N/A0.0%0.00%
    Citius Pharmaceuticals Inc (CTXR)$14.69MN/A1.9x0.0%-84.3%0.0%0.00%
    IRIDEX Corporation (IRIX)$12.12MN/A0.2x-6.9%-18.7%-7.4%0.00%
    Lite Strategy, Inc. (LITS)$25.30MN/AN/A0.0%N/A0.0%0.00%
    CEL-SCI Corp (CVM)$22.51MN/AN/A0.0%-109.0%-62.7%0.00%
    Peer median$12.06MN/A1.2x0.0%-109.0%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Scilex Holding Company, ranked by how closely their business, size, sector and industry match. The largest group, 10 of the 12, is in Biotechnology; the other 2 span 2 industries.

    CompanyAboutPeers
    MIRA Pharmaceuticals, Inc. Common Stock (MIRA)Drug Manufacturers - General
    MIRA Pharmaceuticals, Inc. is a clinical development stage biopharmaceutical company. The company is headquartered in Baltimore, Maryland.
    MIRA competitors
    Context Therapeutics Inc (CNTX)Biotechnology
    Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid...
    CNTX competitors
    Soligenix Inc. (SNGX)Biotechnology
    Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States.
    SNGX competitors
    Ensysce Biosciences Inc (ENSC)Biotechnology
    Ensysce Biosciences, Inc., a clinical-stage biotechnology company, is dedicated to the development of various prescription drugs.
    ENSC competitors
    Exicure Inc (XCUR)Biotechnology
    Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases...
    XCUR competitors
    Phio Pharmaceuticals Corp (PHIO)Biotechnology
    Phio Pharmaceuticals Corp. The company is headquartered in Marlborough, Massachusetts.
    PHIO competitors
    Skye Bioscience, Inc. Common Stock (SKYE)Biotechnology
    Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops...
    SKYE competitors
    Psyence Biomedical Ltd. Common Shares (PBM)Biotechnology
    Psyence Biomedical Ltd. (PBM) is an innovative biotechnology company focused on harnessing the therapeutic potential of psychedelic compounds to address mental...
    Citius Pharmaceuticals Inc (CTXR)Biotechnology
    Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products.
    CTXR competitors
    IRIDEX Corporation (IRIX)Medical Devices
    IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic laser systems, delivery devices...
    IRIX competitors
    Lite Strategy, Inc. (LITS)Biotechnology
    Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer.
    LITS competitors
    CEL-SCI Corp (CVM)Biotechnology
    CEL-SCI Corporation is dedicated to the research and development of immunotherapy for the treatment of cancer and infectious diseases.
    CVM competitors

    Frequently Asked Questions About SCLX

    Who are Scilex Holding Company's main competitors?

    The companies most similar to Scilex Holding Company include MIRA Pharmaceuticals, Inc. Common Stock (MIRA), Context Therapeutics (CNTX), Soligenix (SNGX), Ensysce Biosciences (ENSC) and Exicure (XCUR), listed from the closest match.

    Who is Scilex Holding Company's biggest competitor?

    MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is both the largest of the similar companies at $27.73M and the closest match by business profile, size, sector and industry.

    How does SCLX stock compare with its competitors?

    SCLX's P/S is 0.3x against a peer median of 1.2x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Scilex Holding Company's competitors pays a higher dividend?

    Scilex Holding Company pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Scilex Holding Company bigger than its competitors?

    No. Scilex Holding Company is 8th by market cap among the 13 companies on this page; the largest is MIRA Pharmaceuticals, Inc. Common Stock (MIRA) at $27.73M.